imberg Trial

• Registration Number: NL-OMON22628

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 74

Inclusion Criteria

primary or recurrent pilonidal sinus
width of fistulacomplex between 1 and 3 centimeter
signed informed consent
age: >/= 18 years
mentally competent

Exclusion Criteria

patients with an actual abscess
not able to follow-up
patients in which woundhealing problems are to be expected (Diabetes type II, immunesupression, chemotherapy, HIV/AIDS)
not mentally competent
dementia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tijd tot volledige wondgenezing

Secondary Outcome Measures

Name	Time	Method
Het aantal wondinfecties, het recidiefpercentage binnen 1 jaar, en een aantal factoren die de morbiditeit na de operatie bepalen zullen worden onderzocht.